David Harrison
Impact in
-
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammasome and immune disorders 8
- Sphingolipid Metabolism and Signaling 4
- Heme Oxygenase-1 and Carbon Monoxide 2
- Glycosylation and Glycoproteins Research 1
-
- Macrophage Migration Inhibitory Factor 2
- Co-authors
- Alan P. Watt (7 shared papers)Valérie Reader (3 shared papers)Christopher A. Gabel (6 shared papers)John R. Doedens (5 shared papers)Pamela J. Smolak (5 shared papers)Mark G. Bock (5 shared papers)Keith Cohn (1 shared paper)M. Katharine Holloway (2 shared papers)
- Journals
- Experimental Biology and Medicine (3 papers)Journal of Medicinal Chemistry (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Biochemical Pharmacology (1 paper)Nature (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
David Harrison
15 papers receiving 257 citations
Peers
Comparison fields: 5 of 65
- Biological Psychiatry 9
- Nephrology 25
- Cardiology and Cardiovascular Medicine 52
- Molecular Biology 136
- Biotechnology 16
Countries citing papers authored by David Harrison
This map shows the geographic impact of David Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Harrison more than expected).
Fields of papers citing papers by David Harrison
This network shows the impact of papers produced by David Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Harrison. The network helps show where David Harrison may publish in the future.
Co-authors
The 25 scholars most cited alongside David Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 46 | |
| 2 | 2023 | 40 | |
| 3 | 1971 | 39 | |
| 4 | 2024 | 32 | |
| 5 | 2017 | 28 | |
| 6 | 2013 | 27 | |
| 7 | 1969 | 21 | |
| 8 | 2022 | 15 | |
| 9 | 2024 | 10 | |
| 10 | 2024 | 6 | |
| 11 | 1972 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 1967 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 1962 | 1 | |
| 16 | 1965 | 1 | |
| 17 | Pharmacologic counter measures minimizing post-space flight orthostatic intolerance. [bed rest, drug disposition, and physiological function | 1982 | 1 |
| 18 | 2025 | 0 |
About David Harrison
David Harrison is a scholar working on Molecular Biology, Immunology, Surgery, Cellular and Molecular Neuroscience and Biological Psychiatry, having authored 18 papers that have together received 281 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (8 papers), Sphingolipid Metabolism and Signaling (4 papers), Pharmacological Effects and Assays (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Macrophage Migration Inhibitory Factor (2 papers), Tryptophan and brain disorders (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Biological Psychiatry (9 citations), Nephrology (25 citations), Cardiology and Cardiovascular Medicine (52 citations), Molecular Biology (136 citations) and Biotechnology (16 citations). David Harrison has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Alan P. Watt, Valérie Reader, Christopher A. Gabel, John R. Doedens, Pamela J. Smolak, Mark G. Bock, Keith Cohn, M. Katharine Holloway, Ralph E. Gianelly and Richard Davenport. Their work appears in journals such as Experimental Biology and Medicine, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.